<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Tan Lines</title><description>The full Melanotan II story, told straight: the research that created it, the gray market that hijacked it, the approved drugs it spawned, and the photoprotective medicine that could still come.</description><link>https://melanotanii.com/</link><language>en-us</language><item><title>The Barbie drug: how an unapproved peptide built a global gray market</title><link>https://melanotanii.com/articles/barbie-drug-gray-market/</link><guid isPermaLink="true">https://melanotanii.com/articles/barbie-drug-gray-market/</guid><description>Melanotan II was never approved anywhere, for anything. It sold anyway — through forums, gyms, and &apos;research chemical&apos; sites. This is what that market looks like and what it costs.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>How a suntan became desirable</title><link>https://melanotanii.com/articles/how-a-suntan-became-desirable/</link><guid isPermaLink="true">https://melanotanii.com/articles/how-a-suntan-became-desirable/</guid><description>For most of history, pale skin meant status and a tan meant labor. Then, in one decade, it flipped. The century that made a tan aspirational — Chanel, the Riviera, the sunbed — and set up everything that came after.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>culture</category></item><item><title>How a tan actually protects skin — and why that was the whole idea</title><link>https://melanotanii.com/articles/how-a-tan-protects-skin/</link><guid isPermaLink="true">https://melanotanii.com/articles/how-a-tan-protects-skin/</guid><description>A tan is the body&apos;s own sunscreen: eumelanin absorbing ultraviolet before it reaches DNA. Understanding how melanin protects — and how little — is the key to what Melanotan was reaching for.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>science</category></item><item><title>How the science escaped the lab: the patents that made a gray market inevitable</title><link>https://melanotanii.com/articles/how-the-science-escaped-the-lab/</link><guid isPermaLink="true">https://melanotanii.com/articles/how-the-science-escaped-the-lab/</guid><description>Melanotan II&apos;s structure was published in journals and patents, then orphaned by its own developers. Once the recipe was public and the demand was real, the gray market was only a matter of time.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>history</category></item><item><title>Melanotan I and Melanotan II: one number, two completely different fates</title><link>https://melanotanii.com/articles/melanotan-1-vs-melanotan-2/</link><guid isPermaLink="true">https://melanotanii.com/articles/melanotan-1-vs-melanotan-2/</guid><description>Two peptides from the same Arizona lab, almost the same molecule. One became an approved medicine. The other became the gray market&apos;s favorite. The difference is a lesson in selectivity.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>history</category></item><item><title>The middle-ground agonist already exists. You just can&apos;t have it.</title><link>https://melanotanii.com/articles/middle-ground-agonist-already-exists/</link><guid isPermaLink="true">https://melanotanii.com/articles/middle-ground-agonist-already-exists/</guid><description>Afamelanotide (Scenesse) is an approved, rigorously tested melanocortin drug that protects skin from light. Why it&apos;s locked in a rare-disease label — and what a GLP-1-style breakout would take.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>next-agonist</category></item><item><title>One hormone, five receptors: why Melanotan II did so much more than tan</title><link>https://melanotanii.com/articles/one-hormone-five-receptors/</link><guid isPermaLink="true">https://melanotanii.com/articles/one-hormone-five-receptors/</guid><description>MT-II&apos;s strange effect profile — tanning, appetite, libido — isn&apos;t mysterious. It&apos;s what happens when a non-selective agonist hits the whole melanocortin receptor family at once.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>science</category></item><item><title>Tanorexia: the opioid your skin makes in the sun</title><link>https://melanotanii.com/articles/tanorexia-the-opioid-your-skin-makes/</link><guid isPermaLink="true">https://melanotanii.com/articles/tanorexia-the-opioid-your-skin-makes/</guid><description>Why is a tan so hard to give up? UV light makes your skin manufacture a real opioid. The addiction science — mice, naloxone, and eight frequent tanners — and what it explains about a peptide.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>culture</category></item><item><title>One injection, eight hours, and a second drug hiding inside Melanotan II</title><link>https://melanotanii.com/articles/the-accident-inside-melanotan/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-accident-inside-melanotan/</guid><description>The strangest chapter in the Melanotan story: a University of Arizona self-experiment that produced an eight-hour erection — and pointed the way to an FDA-approved libido drug.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>history</category></item><item><title>The beachhead: the narrow uses that could open the door for everyone</title><link>https://melanotanii.com/articles/the-beachhead-indications/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-beachhead-indications/</guid><description>GLP-1 reached the masses through diabetes first. A photoprotective melanocortin drug has its own candidate beachheads — and one of them, vitiligo, is in Phase III right now.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>next-agonist</category></item><item><title>The influencer era: how the Barbie drug got re-sold</title><link>https://melanotanii.com/articles/the-influencer-era/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-influencer-era/</guid><description>Melanotan II never went away — it went viral. Nasal sprays, flavored drops, and the &apos;vacation peptide&apos; on TikTok. How social media re-packaged an unregulated injectable, and the regulatory gap that lets it sell in the open.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>culture</category></item><item><title>The mole problem: what dermatologists actually fear about Melanotan II</title><link>https://melanotanii.com/articles/the-mole-problem/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-mole-problem/</guid><description>Melanotan II darkens and multiplies moles — and the deeper danger is diagnostic. The case reports, the unresolved melanoma question, and why a changing mole is the exact signal you don&apos;t want to lose.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>The prevention-trial problem: why &apos;stops skin cancer&apos; is so hard to prove</title><link>https://melanotanii.com/articles/the-prevention-trial-problem/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-prevention-trial-problem/</guid><description>A drug that prevents skin cancer in healthy people would need one of the longest, largest, most expensive trials in medicine. Why the evidence bar — not the chemistry — is the real wall.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>next-agonist</category></item><item><title>The side-effect ledger: what Melanotan II is actually documented to do</title><link>https://melanotanii.com/articles/the-side-effect-ledger/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-side-effect-ledger/</guid><description>Separating what Melanotan II reliably does from forum lore and worst-case rumor: the acute effects, the pigment effects, and the rare serious events that actually reach the medical literature.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>The tan without the sun: what a peptide short-circuits that UV does the hard way</title><link>https://melanotanii.com/articles/the-tan-without-the-sun/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-tan-without-the-sun/</guid><description>A suntan is a wound response — pigment the skin makes only after ultraviolet has already damaged its DNA. Melanotan&apos;s elegant idea was to get the pigment without the damage that normally triggers it.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>science</category></item><item><title>The three doors: the U.S. regulatory map for a melanocortin sun drug</title><link>https://melanotanii.com/articles/the-three-doors/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-three-doors/</guid><description>Melanotan II is illegal in America — but the technology it previewed is not. A primer on the U.S. regulatory landscape (FDA approval, compounding, and the gray market) for the melanocortin agonists that give skin photoprotection without the sun.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>next-agonist</category></item><item><title>What a safe tanning drug would actually have to be</title><link>https://melanotanii.com/articles/what-a-safe-tanning-drug-requires/</link><guid isPermaLink="true">https://melanotanii.com/articles/what-a-safe-tanning-drug-requires/</guid><description>Not a vial from a forum — a real one. The four things a general-public photoprotective drug would need to clear, and how far today&apos;s science already is toward each. Analysis, labeled as such.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>next-agonist</category></item><item><title>You can&apos;t know what&apos;s in the vial</title><link>https://melanotanii.com/articles/whats-in-the-vial/</link><guid isPermaLink="true">https://melanotanii.com/articles/whats-in-the-vial/</guid><description>Gray-market Melanotan II is an unregulated injectable, made by unknown labs and reconstituted at the kitchen table. Purity, sterility, and dose are all assumptions — and assumptions have sent people to the ER.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>The sunscreen you&apos;d never have to reapply: where Melanotan came from</title><link>https://melanotanii.com/articles/where-melanotan-came-from/</link><guid isPermaLink="true">https://melanotanii.com/articles/where-melanotan-came-from/</guid><description>Melanotan II wasn&apos;t invented for tanning salons. It came out of 1980s melanoma-prevention research at the University of Arizona — and the original goal was saving lives.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>history</category></item><item><title>Why a cosmetic went underground</title><link>https://melanotanii.com/articles/why-a-cosmetic-went-underground/</link><guid isPermaLink="true">https://melanotanii.com/articles/why-a-cosmetic-went-underground/</guid><description>Melanotan II may be the most self-injected drug no regulator ever approved. The reason isn&apos;t only lax enforcement — it&apos;s that it served a want, not a need, and wants don&apos;t wait for clinical trials.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>culture</category></item><item><title>Why redheads burn: the MC1R gene and the pigment switch</title><link>https://melanotanii.com/articles/why-redheads-burn-mc1r/</link><guid isPermaLink="true">https://melanotanii.com/articles/why-redheads-burn-mc1r/</guid><description>Red hair, freckles, and burning instead of tanning all trace to one receptor: MC1R. It&apos;s the same keyhole every Melanotan was cut to fit — and a melanoma risk gene in its own right.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>science</category></item></channel></rss>